Methode Electronics (NYSE:MEI) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.52 by 11.54 percent. This is a 23.68 percent decrease over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $282.40 million which missed the analyst consensus estimate of $286.35 million by 1.38 percent. This is a 1.88 percent decrease over sales of $287.80 million the same period last year.
CytoSorbents Reports Outcomes From A Randomized Controlled Trial Using CytoSorb Blood Purification During Heart Transplant, Recently Published In The European Society Of Cardiology Journal, ESC Heart Failure
Better hemodynamic stability and lower rates of post-operative shock
Patients in the CytoSorb group had lower median Vasoactive-Inotropic Scores (27.2 [14.6–47.7] vs. 41.9 [22.4–63.2], p=0.046) and
